Atlas Trials

Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia

Clinical trial NCT05203055 · UNKNOWN

Trial details

NCT number
NCT05203055
Sponsor
Fuzhou General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia
Start date
2021-12-10
Primary completion
2022-12-10
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.